10,042 reports of this reaction
2.3% of all ATORVASTATIN CALCIUM reports
#7 most reported adverse reaction
PAIN is the #7 most commonly reported adverse reaction for ATORVASTATIN CALCIUM, manufactured by Parke-Davis Div of Pfizer Inc. There are 10,042 FDA adverse event reports linking ATORVASTATIN CALCIUM to PAIN. This represents approximately 2.3% of all 446,126 adverse event reports for this drug.
Patients taking ATORVASTATIN CALCIUM who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for ATORVASTATIN CALCIUM, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for ATORVASTATIN CALCIUM:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 10,042 FDA reports for ATORVASTATIN CALCIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 2.3% of all adverse event reports for ATORVASTATIN CALCIUM, making it a notable side effect.
If you experience pain while taking ATORVASTATIN CALCIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.